Advertisement

Trophic Factors and Parkinson’s Disease

  • W. H. Oertel
  • A. Kupsch
Part of the Advances in Research on Neurodegeneration book series (ARN, volume 2)

Abstract

During the development period, neurons are abundantly generated in the vertebrate nervous system. Following the arrival of their axons in the target areas, only a proportion of these neurons will survive. These neurons are thought to have successfully competed for a target-derived, retrogradely transported neurotrophic factor, present in limited amounts in the target fields. Such a neurotrophic factor, in its narrow definition, is a survival factor for embryonic neurons in either the peripheral or central nervous system. This definition is derived from research on nerve growth factor (NGF) (Levi-Montalcini and Booker, 1960). NGF belongs to the family of “neurotrophic,” which subsumes brain-derived neurotrophic factor (BDNF; for reviews, see Barde, 1989; Levi-Montalcini, 1987; Thoenen et al., 1987), neurotrophin-3/neurotrophin 4 (NT-3/NT-4; see Glass et al., 1991; Hohn et al, 1990), and neurotrophin 5 (NT-5; see Berkemeier et al., 1991). In addition, a number of other nontarget-derived molecules are known to influence survival and differentiation of certain neurons and nonneuronal cells. These factors include ciliary neurotrophic factor (CNTF), acidic and basic fibroblast growth factor (FG F-1 and FGF-2, respectively), epidermal growth factor (EGF), insulin-like growth factors I and II (IGF-I, IGF-II), and muscle-derived differentiation factor (MDF).

Keywords

Nerve Growth Factor Neurotrophic Factor Dopaminergic Neuron Trophic Factor Ciliary Neurotrophic Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alderson RF, Alterman AL, Barde, YA, Lindsay RM (1990): Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5:297–306PubMedCrossRefGoogle Scholar
  2. Altar CA, Boylan CB, Jackson C, Hershensson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C (1992): Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover. Proc Natl Acad Sci (USA) 89:11347–11351CrossRefGoogle Scholar
  3. Anderson DJ, Axel R (1986): A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell 47:1079–1090PubMedCrossRefGoogle Scholar
  4. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, Porrino L, Di Porzio U, London WT, Kopin IJ, Oldwin EH (1990): The effect of fetal mesencephalic implants on primate MPTP-induced parkinsonism. Histochemical and behavioural studies. Neurosurgery 72:231–244CrossRefGoogle Scholar
  5. Barde YA (1989): Trophic factors and neuronal survival. Neuron 2:1525–1534PubMedCrossRefGoogle Scholar
  6. Bean AJ, Elde R, Cao YH, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hökfelt T (1991): Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc Natl Acad Sci (USA) 88:10237–10241CrossRefGoogle Scholar
  7. Beck KD, Knüsel B, Winslow JW, Rosenthal A, Burton LE, Nikolics K, Hefti F (1992): Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium. Neurodegeneration 1:27–36Google Scholar
  8. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A (1991): Neurotrophin 5, a novel neurotrophic factor that activates trk and trkB. Neuron 7:857–866PubMedCrossRefGoogle Scholar
  9. Bohn MC, Cupit L, Marciano F, Gash DM (1987): Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237:913–916PubMedCrossRefGoogle Scholar
  10. Cintra A, Cao YH, Oellig C, Tinner B, Bortolotti F, Goldstein M, Pettersson RF, Fuxe K (1991): Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. Neuroreport 2:597–600PubMedCrossRefGoogle Scholar
  11. Davis S, Yancopoulos GD (1993): The molecular biology of the CNTF receptor. Curr Opin Neurobiol 3:20–24PubMedCrossRefGoogle Scholar
  12. Dreyfus CF (1989): Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol Sci 10:145–149PubMedCrossRefGoogle Scholar
  13. Engele J, Bohn MC (1991): The neurotrophic effects of fibroblast growth factor in vitro are mediated by mesencephalic glia. J Neurosci 11:3070–3078PubMedGoogle Scholar
  14. Fallon (1984): Epidermal growth factor immunoreactive material in the central nervous system: location and development. Science 224:1107–1109PubMedCrossRefGoogle Scholar
  15. Ffrench-Constant C (1992): Cell death: a division too far? Curr Opin Biol 2:577–579Google Scholar
  16. Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M, Yancopoulos GD (1991): TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell 66:405–413PubMedCrossRefGoogle Scholar
  17. Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH (1991): Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J Neurochem 57:479–482PubMedCrossRefGoogle Scholar
  18. Hagg T, Varon S (1993): Ciliary neurotrophic factor (CNTF) prevents axotomyinduced degeneration of adult rat substantia dopaminergic neurons. Proc Natl Acad Sci USA 90:6315–6319PubMedCrossRefGoogle Scholar
  19. Hefti F (1986): Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155–2162PubMedGoogle Scholar
  20. Hirsch EC, Duychaerts C, Javoy-Agid F, Hauw I-J, Agid Y (1990): Does adrenal graft enhance recovery of dopaminergic fibres in Parkinson’s disease? Ann Neurol 27:676–682PubMedCrossRefGoogle Scholar
  21. Hohn A, Leibrock J, Bailey K, Barde Y-A (1990): Identification and characterization of a novel member of the nerve growth factor/brain derived neurotrophic factor family. Nature 344:339–341PubMedCrossRefGoogle Scholar
  22. Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991): BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230–232PubMedCrossRefGoogle Scholar
  23. Iacovitti L (1991): Effects of a novel differentiation factor on the development of catecholamine traits in noncatecholamine neurons from various regions of the rat brain: studies in tissue culture. J Neurosci 11:2403–2409PubMedGoogle Scholar
  24. Iacovitti L, Evinger MJ, Stull ND (1992): Muscle-derived differentiation factor increases expression of the tyrosine hydroxylase gene and enzyme activity in cultured dopamine neurons from the rat midbrain. Mol Brain Res 16:215–222PubMedCrossRefGoogle Scholar
  25. Ichitani A, Okumara H, Matsumoto A, Nagatsu I, Iabata Y (1991): Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection in the rat striatum. Brain Res 549:350–353PubMedCrossRefGoogle Scholar
  26. Ip NY, Li Y, von de Stadt I, Panayotatos N, Alderson RF, Lindsay RM (1991): Ciliary neurotrophic factor enhances neuronal survival in embryonic rat hippocampal cultures. J Neurosci 11:3124–3134PubMedGoogle Scholar
  27. Jin BK, Schneider JS, Du YY, Iacovitti L (1991): MDF, a muscle factor, produces partial motor recovery in 6-hydroxydopamine lesioned rats by increasing tyrosine hydroxylase activity and catechol levels. Soc Neurosci Abstr 18:1296Google Scholar
  28. Knüsel B (1990): Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cells. Exp Neurol 110:274–283PubMedCrossRefGoogle Scholar
  29. Knüsel B, Michel PP, Schwaber JS, Hefti F (1990): Selective and nonselective Stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast factor, epidermal growth factor, insulin and insulin-like growth factors I and II. J Neurosci 10:558–570PubMedGoogle Scholar
  30. Knüsel B, Winslow JW, Rosenthal A, Burton LE, Scid DP, Nikolics K, Hefti F (1991): Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci (USA) 88:961–965CrossRefGoogle Scholar
  31. Knüsel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmer HR, Nikolics K, Hefti F (1992): Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391–4402PubMedGoogle Scholar
  32. Levi-Montalcini R (1987): The nerve growth factor: thirty-five years later. EMBO J 6:1145–1154PubMedGoogle Scholar
  33. Levi-Montalcini R, Booker R (1960): Destruction of the sympathetic ganglia in mammals by an anti-serum to the nerve growth factor. Proc Natl Acad Sci (USA) 46:364–391Google Scholar
  34. Lewis EJ, Chikaraishi DM (1987): Regulated expression of the tyrosine hydroxylase gene by epidermal growth factor. Mol Cell Biol 7:3332–3336PubMedGoogle Scholar
  35. Nistico G, Ciriolo MR, Fiskin K, Iannone M, De-Martino A, Rotilio G (1992): NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radical Biol Med 12:177–181CrossRefGoogle Scholar
  36. Olson L, Backlund EO, Ebendal T, Freedman R, Hamberger B, Hansson P, Hoffer B, Lindblom U, Meyerson B, Strömberg I, Sydow O, Sciger A (1991): Intraputam-inal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson’s disease. Arch Neurol 48:373–381PubMedCrossRefGoogle Scholar
  37. Otto D, Unsicker K (1990): Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10:1912–1921PubMedGoogle Scholar
  38. Otto D, Unsicker K (1992): Effects of FGF-2 on dopamine neurons. Neurosci Facts 3:882–883Google Scholar
  39. Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A (1991): Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats. Mov Disord 6:281–287PubMedCrossRefGoogle Scholar
  40. Sauer H, Fischer W, Nikkah G, Brundin P, Lindsay RM, Björklund A (1993): Brain-derived neurotrophic factor enhances function rather than survival of intra-striatal ventral mesencephalic grafts. Brain Res 626:37–44PubMedCrossRefGoogle Scholar
  41. Sendtner M, Kreutzberg GW, Thoenen H (1990): Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345:440–441PubMedCrossRefGoogle Scholar
  42. Sendtner M, Schmalbruch H, Stöckli KA, Caroll P, Kreutzberg G, Thoenen H (1992): Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358:502–504PubMedCrossRefGoogle Scholar
  43. Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, Glass DJ, Masiakowski P, Furth ME, Valenzuela DM (1991): TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65:885–893PubMedCrossRefGoogle Scholar
  44. Steinbusch HW, Vermeulen RJ, Tonnaer JA (1990): Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: preliminary observations. Prog Brain Res 82:81–86PubMedCrossRefGoogle Scholar
  45. Stöckli KA, Lottspeich F, Sendtner M, Masiakowski P, Carroll P, Götz R, Lindholm D, Thoenen H (1989): Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 342:920–923PubMedCrossRefGoogle Scholar
  46. Strömberg I, Herrera-Marschitz M, Ungerstedt U, Ebendal T, Olson L (1985): Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behaviour. Exp Brain Res 60:335–349PubMedCrossRefGoogle Scholar
  47. Tatton WG, Greenwood CE (1991): Rescue of dying neurons: a new action of deprenyl in MPTP parkinsonism. J Neurosci Res 30:666–672PubMedCrossRefGoogle Scholar
  48. Thoenen H (1991): The changing scene of neurotrophic factors. Trends Neurosci 14:165–170PubMedCrossRefGoogle Scholar
  49. Thoenen H, Bandtlow C, Heumann R (1987): The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 109:145–178PubMedCrossRefGoogle Scholar
  50. Wiegand SJ, Anderson K, Alexander C, Criden M, Altar CA, Lindsay RM, Distefano PS (1992): Receptor binding and axonal transport of [125I]-labeled neurotrophins in the basal ganglia and related brain regions. Mov Disord 7, Suppl. 1, Abstr. P147B, p. 63Google Scholar
  51. Zafra F, Castrén E, Thoenen H, Lindholm D (1991): Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci (USA) 88:10027–10041CrossRefGoogle Scholar

Copyright information

© Birkhäuser Boston 1994

Authors and Affiliations

  • W. H. Oertel
  • A. Kupsch

There are no affiliations available

Personalised recommendations